Simavita Limited: Results From 2014 Annual General and Special Meeting
(firmenpresse) - SYDNEY, AUSTRALIA -- (Marketwired) -- 12/03/14 -- Simavita Limited ("Simavita" or the "Company") (ASX: SVA)(TSX VENTURE: SV) advises that the 2014 Annual General and Special Meeting of shareholders was held at 10.00 am today (Sydney time) at the offices of Dibbs Barker, Level 8, 123 Pitt Street, Sydney, New South Wales, Australia.
All six resolutions that were put before the shareholders were passed on a show of hands.
In respect of resolution 4, in which the Company sought shareholder approval under ASX Listing Rule 7.1A, we confirm that the resolution was passed by a sufficient majority as a special resolution (with 98.44% voting in favour), as set out on the attached page.
The proxy votes received in respect of the various resolutions are set out on the attached page.
For further information, please visit the Company''s profile on SEDAR () or the Company''s website () or contact the persons outlined below.
About Simavita
Simavita is a medical device company operating in the digital healthcare sector that has developed an innovative, world first solution for the management of urinary incontinence, with a focus on the elderly. The first product is the SIM™ platform technology which is an instrumented incontinence assessment application that provides evidence based incontinence management care plans to the residential aged care market.
About SIM™
SIM™ is a wireless sensor technology that delivers evidence-based instrument incontinence data on individuals. SIM™ provides user friendly tools and software to assess the incontinence condition and to help plan better outcomes. SIM™ is used to detect, record and report incontinence events during a compulsory or recommended assessment period in residential aged care facilities to develop an evidence-based incontinence care plan.
Conducting assessments is mandatory in many countries and the incontinence assessment creates an influential element of care of each individual. For more information on Simavita or SIM™, please visit .
The TSX Venture Exchange has in no way passed upon the merits of the transactions set out herein and has neither approved nor disapproved the contents of this press release. Neither TSX Venture Exchange not its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this Release.
Proxy results for 2014 Annual General and Special Meeting
Notes: The Company currently has a total of 73,727,743 common shares on issue and 849 registered share/CDI holders.
Contacts:
Company
Philippa Lewis
Chief Executive Officer
+61 2 8405 6381
Thomas Howitt
Chief Financial Officer
+ 61 418 351 127
Media and Investor Relations
Buchan Consulting
Annabel Murphy
+61 2 9237 2800
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 03.12.2014 - 12:00 Uhr
Sprache: Deutsch
News-ID 1322840
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
SYDNEY, AUSTRALIA
Phone:
Kategorie:
Alternative
Anmerkungen:
Diese Pressemitteilung wurde bisher 180 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Simavita Limited: Results From 2014 Annual General and Special Meeting
"
steht unter der journalistisch-redaktionellen Verantwortung von
Simavita Limited (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
